MOUNTAIN VIEW, CA--(Marketwired - Jan 22, 2015) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the world's first intravascular ...
WASHINGTON -- The same year that the FDA warned against long-term use of inferior vena cava (IVC) filters, placement rates took a downward turn, researchers said. Separately, one center reported ...
The patient with both recent bleeding and thrombotic events poses a great challenge to clinicians. The rationale for an IVC filter is that it would potentially reduce the risk of morbid or fatal ...
Please provide your email address to receive an email when new articles are posted on . Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates ...
More than one-third of patients undergoing catheter-directed thrombolysis of deep vein thrombosis receive an inferior vena cava (IVC) filter, yet placement of the device is not associated with a ...
Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin. Background: Venous thrombosis is a frequent ...
Use of inferior vena cava (IVC) filters declined in the United States following a 2010 safety communication from the US Food and Drug Administration (FDA), although the rate of implantation remains ...
Inferior vena cava (IVC) filters are widely used in patients who cannot take blood thinners. The IVC is the largest vein in the body, running from the legs to the chest. IVC filters keep blood clots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback